Improved heat shock protein-based vaccines and immunotherapies

Details Improved heat shock protein-based vaccines and immunotherapies Improved heat shock protein-based vaccines and immunotherapies

C - Chemistry, Metallurgy

07

K

C07K 19/00 (2006.01) A61K 38/08 (2006.01) A61K 38/17 (2006.01) A61K 39/00 (2006.01) A61P 35/00 (2006.01) C07K 7/06 (2006.01) C07K 14/47 (2006.01)

Patent

CA 2520591

Hybrid antigens comprising an antigenic domain and improved heat shock protein binding domains are described which are useful for the induction of an immune response to the antigenic domain and thus can be used to treat infectious diseases and cancers that express an antigen of the antigenic domain.

L'invention concerne des antigènes hybrides comprenant un domaine antigénique et des domaines de liaison à la protéine de choc thermique améliorés, qui sont utiles pour l'induction d'une réaction immunitaire au domaine antigénique et qui peuvent être utilisés pour le traitement des maladies infectieuses et des cancers qui expriment un antigène dudit domaine antigénique.

Affiliated with

Also associated with

Rating

Improved heat shock protein-based vaccines and immunotherapies does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Improved heat shock protein-based vaccines and immunotherapies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Improved heat shock protein-based vaccines and immunotherapies will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1674355